Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
11.80
+0.50 (4.42%)
Feb 25, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Software
180.37M159.12M135.58M113.24M92.53M
Software Growth
13.35%17.37%19.73%22.38%38.65%
Drug Discovery
27.17M57.54M45.38M24.70M15.57M
Drug Discovery Growth
-52.78%26.81%83.75%58.66%-17.24%
Total
207.54M216.67M180.96M137.93M108.10M
Total Growth
-4.21%19.73%31.19%27.60%26.36%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
United States
114.87M161.96M123.56M90.40M60.74M
United States Growth
-29.08%31.08%36.68%48.84%27.54%
Emea
65.65M29.14M34.45M28.88M-
Emea Growth
125.33%-15.43%19.29%--
Apac
25.80M24.57M21.68M17.78M-
Apac Growth
5.02%13.33%21.95%--
Rest of World
1.22M1.00M1.27M875.00K8.43M
Rest of World Growth
21.68%-21.06%44.91%-89.62%39.34%
Europe
----24.37M
Europe Growth
----39.23%
Japan
----14.56M
Japan Growth
----1.33%
Total
207.54M216.67M180.96M137.93M108.10M
Total Growth
-4.21%19.73%31.19%27.60%26.36%
Source: S&P Global Market Intelligence.